Suven Life Sciences share news and announcements
NSE: SUVENBSE: 530239Healthcare ServicesSmall Cap
Last close ₹261.35down ₹6.85 (2.55%)BSE ₹261.80
Share price at the NSE close on 23 Oct 2026. Previous close ₹268.20.
52-week range of traded prices to 23 Oct 2026
₹124.11Low, 24 Mar 2026₹403.35High, 1 Sep 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹7,385 Cr806th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 6 Aug 2026
- −100.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 6 Aug 2026
- −63.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 13 May 2026
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 10,72,06841.2% delivered
Suven Life Sciences routine notices
146 filed, newest first. Page 1 of 3.
Oct 2026
23 Oct · Routine
Sep 2026
28 Sep · Routine
Aug 2026
7 Aug · Routine
Jul 2026
31 Jul · Routine
14 Jul · Routine
Jun 2026
May 2026
14 May · Routine
Apr 2026
23 Apr · Routine
Mar 2026
25 Mar · Routine
Feb 2026
19 Feb · Routine
Jan 2026
30 Jan · Routine
Dec 2025
Nov 2025
12 Nov · Routine
Oct 2025
Sep 2025
Aug 2025
14 Aug · Routine
14 Aug · Routine
Jul 2025
Jun 2025
May 2025
15 May · Routine
14 May · Routine
Apr 2025
Mar 2025
Jan 2025
25 Jan · Routine
Dec 2024
3 Dec · Routine
Oct 2024
30 Oct · Routine
Sep 2024
Aug 2024
6 Aug · Routine
Jul 2024
5 Jul · Routine
Jun 2024
29 Jun · Routine
May 2024
8 May · Routine
Apr 2024
Mar 2024
Feb 2024
3 Feb · Routine
Jan 2024
31 Jan · Routine
Dec 2023
1 Dec · Routine
Nov 2023
6 Nov · Routine